Botulinum toxin A should not be first-line therapy for overactive bladder

被引：4
作者：
Carr, Lesley K. [1 ]
机构：
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON M4N 3M5, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2011年 / 5卷 / 03期
关键词：
URGE URINARY-INCONTINENCE; DETRUSOR OVERACTIVITY; CONTROLLED-TRIAL; DOUBLE-BLIND; INJECTIONS; ONABOTULINUMTOXINA; EXPERIENCE; EFFICACY; MUSCLE;
D O I：
10.5489/cuaj.11044
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：204 / 205
页数：2
相关论文
共 14 条
[1]   Refractory idiopathic urge urinary incontinence and botulinum A injection [J].
Brubaker, Linda ;
Richter, Holly E. ;
Visco, Anthony ;
Mahajan, Sangeeta ;
Nygaard, Ingrid ;
Braun, Thomas M. ;
Barber, Matthew D. ;
Menefee, Shawn ;
Schaffer, Joseph ;
Weber, Anne M. ;
Wei, John .
JOURNAL OF UROLOGY, 2008, 180 (01) :217-222
[2]   Behavioral vs drug treatment for urge urinary incontinence in older women - A randomized controlled trial [J].
Burgio, KL ;
Locher, JL ;
Goode, PS ;
Hardin, JM ;
McDowell, BJ ;
Dombrowski, M ;
Candib, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (23) :1995-2000
[3]   Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial [J].
Dmochowski, Roger ;
Chapple, Christopher ;
Nitti, Victor W. ;
Chancellor, Michael ;
Everaert, Karel ;
Thompson, Catherine ;
Daniell, Grace ;
Zhou, Jihao ;
Haag-Molkenteller, Cornelia .
JOURNAL OF UROLOGY, 2010, 184 (06) :2416-2422
[4]   Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity [J].
Dowson, Christopher ;
Khan, Mohammad Shamim ;
Dasgupta, Prokar ;
Sahai, Arun .
NATURE REVIEWS UROLOGY, 2010, 7 (12) :661-667
[5]  
HERSCHORN S, J UROL IN PRESS
[6]   The patient with an overactive bladder - Symptoms and quality-of-life issues [J].
Jackson, S .
UROLOGY, 1997, 50 (6A) :18-22
[7]   Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre [J].
Kalsi, V ;
Popat, RB ;
Apostolidis, A ;
Kavia, R ;
Odeyemi, IAO ;
Dakin, HA ;
Warner, J ;
Elneil, S ;
Fowler, CJ ;
Dasqupta, P .
EUROPEAN UROLOGY, 2006, 49 (03) :519-527
[8]   Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder:: A systematic literature review [J].
Karsenty, Gilles ;
Denys, Pierre ;
Amarenco, Gerard ;
De Seze, Marianne ;
Game, Xavier ;
Haab, Francois ;
Kerdraon, Jacques ;
Perrouin-Verbe, Brigitte ;
Ruffion, Alain ;
Saussine, Christian ;
Soler, Jean-Marc ;
Schurch, Brigitte ;
Chartier-Kastler, Emmanuel .
EUROPEAN UROLOGY, 2008, 53 (02) :275-287
[9]  
Kuo HC, 2010, EUR UROL
[10]   Meta-Analysis of Neutralizing Antibody Conversion with OnabotulinumtoxinA (BOTOX®) Across Multiple Indications [J].
Naumann, Markus ;
Carruthers, Alastair ;
Carruthers, Jean ;
Aurora, Sheena K. ;
Zafonte, Ross ;
Abu-Shakra, Susan ;
Boodhoo, Terry ;
Miller-Messana, Mary Ann ;
Demos, George ;
James, Lynn ;
Beddingfield, Frederick ;
VanDenburgh, Amanda ;
Chapman, Mary Ann ;
Brin, Mitchell F. .
MOVEMENT DISORDERS, 2010, 25 (13) :2211-2218
12